Target Name: CAGE1
NCBI ID: G285782
Review Report on CAGE1 Target / Biomarker Content of Review Report on CAGE1 Target / Biomarker
CAGE1
Other Name(s): CAGE1_HUMAN | cancer/testis antigen gene 1 | FLJ40441 | cancer/testis antigen 95 | Cancer antigen 1, transcript variant 3 | bA69L16.7 | Cancer-associated gene 1 | Cancer-associated gene 1 protein (isoform 3) | CT3 | CAGE-1 | cancer antigen 1 | Cancer/testis antigen gene 1 | Cancer/testis antigen 3 | cancer/testis antigen 3 | Cancer/testis antigen 95 | CT95 | CTAG3 | Cancer-associated gene 1 protein | CAGE1 variant 3

CAGE1: Regulator of Cell Adhesion and Cellular Progression

CAGE1 (CAGE1_HUMAN) is a protein that is expressed in various tissues of the human body. It is a key regulator of cell adhesion and has been implicated in a number of diseases, including cancer.

One of the main functions of CAGE1 is to regulate cell-cell adhesion. This is the process by which cells stick together to form tissues and organs. CAGE1 helps to ensure that cells stick together in a orderly and precise manner, which is essential for normal development and wound healing.

CAGE1 has also been shown to play a key role in the regulation of cell proliferation. In fact, studies have suggested that CAGE1 may help to control the growth and division of cancer cells. This may be because cancer cells often have problems with cell adhesion and can easily migrate and spread throughout the body. By regulating cell adhesion, CAGE1 may help to prevent cancer cells from undergoing rapid and uncontrolled growth.

In addition to its role in cell adhesion and proliferation, CAGE1 has also been shown to play a key role in the regulation of tissue repair and regeneration. This is important for the healthy functioning of various tissues, including blood vessels, hearts, and lungs.

CAGE1 has been shown to help ensure that new blood vessels form properly after injury or illness. This is important for maintaining blood flow to the body's tissues and is essential for delivering oxygen and nutrients to the cells that need them.

CAGE1 has also been shown to play a key role in the regulation of cell death. This is the process by which cells are programmed to stop functioning and undergo programmed cell death, also known as apoptosis. In diseases such as cancer, abnormal cell death can contribute to the development and progression of the disease. By regulating cell death, CAGE1 may help to prevent the buildup of abnormal cells that can lead to cancer.

In conclusion, CAGE1 (CAGE1_HUMAN) is a protein that is expressed in various tissues of the human body that plays a critical role in the regulation of cell adhesion, proliferation, tissue repair and regeneration, and cell death. Its role in these processes is essential for the healthy functioning of various tissues and organs, and CAGE1 may be a valuable drug target or biomarker for the development of various diseases.

Protein Name: Cancer Antigen 1

The "CAGE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CAGE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CAHM | CALB1 | CALB2 | CALCA | CALCB | Calcium channel | Calcium release-activated channel (CRAC) | Calcium-activated chloride channel regulators | Calcium-Activated K(Ca) Potassium Channel | CALCOCO1 | CALCOCO2 | CALCR | CALCRL | CALCRL-AS1 | CALD1 | CALHM1 | CALHM2 | CALHM3 | CALHM4 | CALHM5 | CALHM6 | CALM1 | CALM2 | CALM2P1 | CALM2P2 | CALM3 | CALML3 | CALML3-AS1 | CALML4 | CALML5 | CALML6 | Calmodulin | CALN1 | Calpain | Calpain-13 | Calprotectin | CALR | CALR3 | CALU | CALY | CAMK1 | CAMK1D | CAMK1G | CAMK2A | CAMK2B | CAMK2D | CAMK2G | CAMK2N1 | CAMK2N2 | CAMK4 | CAMKK1 | CAMKK2 | CAMKMT | CAMKV | CAMLG | CAMP | cAMP Phosphodiesterase | cAMP Responsive Element Binding Protein (CREB) | cAMP-Dependent protein kinase (PKA) | CAMSAP1 | CAMSAP2 | CAMSAP3 | CAMTA1 | CAMTA2 | CAND1 | CAND1.11 | CAND2 | Cannabinoid receptor | CANT1 | CANX | Cap-binding complex | CAP1 | CAP2 | CAPG | CAPN1 | CAPN10 | CAPN10-DT | CAPN11 | CAPN12 | CAPN13 | CAPN14 | CAPN15 | CAPN2 | CAPN3 | CAPN5 | CAPN6 | CAPN7 | CAPN8 | CAPN9 | CAPNS1 | CAPNS2 | CAPRIN1 | CAPRIN2 | CAPS | CAPS2 | CAPSL | CAPZA1 | CAPZA2 | CAPZA3 | CAPZB